Copyright
©The Author(s) 2023.
World J Stem Cells. May 26, 2023; 15(5): 281-301
Published online May 26, 2023. doi: 10.4252/wjsc.v15.i5.281
Published online May 26, 2023. doi: 10.4252/wjsc.v15.i5.281
TME factor | Action | Ref. |
Growth/inducible factors | ||
Epidermal growth factor | Regulates and promotes CCSC growth | [50] |
Insulin-like growth factor | Regulates and promotes CCSC growth | [50] |
TGF-β | Participates in the initiation of the EMT, invasion, metastasis and initiation of angiogenesis associated to CCSC | [13,29,50] |
Bone mophogenetic protein 4 | Induces differentiation and decreases the tumorigenic potential of CCSC | [16,60,63] |
Bone mophogenic protein 2 | Stimulates the differentiation of CCSC inducting autophagic degradation of β-catenin | [44,63] |
Hepatocyte growth factor | Activates Wnt signaling and the clonogenicity from CCSC | [53,54] |
Macrophage migration inhibitory factor | Increases CCSC properties | [49] |
Vascular endothelial growth factor | Promotes growth, epithelial to mesenchymal transition and stemness | [50,51] |
Platelet derived growth factor | Promotes growth, epithelial to mesenchymal transition and stemness | [50] |
Osteopontin | Regulates EMT and participates in the activation of the Wnt/β-catenin signaling pathway, promoting stemness | [4,156] |
HIF-1A | Activates Wnt/β-catenin pathway inducing self-renewal of CCSC. Promotes survival and maintenance of CCSC | [40,157] |
Citokines/immune associated proteins | ||
IL-1β | Modulates the expression of CCSC markers | [158] |
IL-4 | Facilitates the communication of CCSC with stromal cell, maintains their properties and evades the immune system | [5,44] |
IL-6 | Promotes the expression of the CCSC markers, ALDH1 and LGR5 | [1,47] |
IL-8 | Induces stemness and EMT | [50,159] |
IL-17A | Promotes invasiveness and self-renewal and increases CCSC properties | [12] |
IL-22 | Promotes invasiveness and self-renewal and increases CCSC properties | [12] |
IL-33 | Induces the expression of core stem cell genes in CRC-derived cells | [160] |
Chemokine (C-C motif) ligand 2 | Promotes CCSC properties | [4,49] |
Tumor necrosis factor- α | Modulates CCSC features and induces cell death | [158,161] |
Parathyroid hormone related-protein | Activates Wnt/β-catenin pathway and promotes events related to stemness | [162-164] |
Non-coding RNA | ||
miR-135 a/b and miR-17 | Promote stemness through the activation of Wnt/β-catenin signaling | [157] |
miR-34 and miR-93 | Inhibit stemness | [157] |
miR-92a-3p | Promotes Wnt signaling activation and consequently the expression of β-catenin target genes related to stemness, the EMT program, and chemoresistance | [165] |
miR-20a and miR-106 a/b | Repress TGF-β activity and stemness | [157] |
miR-146 and Let-7 | Affect stem cell fate or proliferation, activation of several stemness markers in a colon cancer cell line | [157] |
miR-221/222 and miR-21 | Induce the development and maintenance of CCSC | [157] |
miR-21 | Promotes the activation of the Wnt/β-catenin signaling pathway and increases the population of CCSC | [157] |
miR-145 | Represses miR-21 and its expression inversely correlates with that of CCSC markers | [157,166] |
miR-137 | Suppresses CCSC tumorigenicity | [167] |
miR-147 | Decreases the expression of CCSC markers | |
miR-200, miR-203, miR-141 and miR-429 | Regulate CCSC through negative modulation of EMT and self-renewal | [157] |
lncRNA H19 | Promotes CCSC phenotype and drug resistance | [168] |
Signaling pathway ligands | ||
Wnt ligands | Increase CCSC characteristics and enhances tumor-initiating potential | [5,157] |
Delta like canonical Notch ligand 4 | Participates on CSC maintenance | [44] |
Jagged1 | Participates on CSC maintenance | [66] |
SHH | Promotes CCSC survival, self-renewal and drug resistance | [67,68] |
Enzymes | ||
Phospholipase D2 | Promotes CRC stemness | [4,49] |
Extra-cellular matrix components | ||
Tenascin, fibronectin, collagen type I, secreted protein acidic and rich in cysteine, galectin | Contribute to stemness and CCSC activities | [1] |
CMS1-immune (14%) | CMS2-canonical (37%) | CMS3-metabolic (13%) | CMS4-mesenchymal (23%) | Unclassified (13%) | |
General features | Hypermutated | Epithelial | Epithelial | TGF-β activation. Angiogenesis | Mixed phenotype of multiple CMS |
Microsatellite unstable | WNT and MYC signaling activation | Metabolic dysregulation | Upregulation of EMT | ||
Mutations | BRAF, MSH6, RNF43, ATM, TGFBr2, PTEN | APC, KRAS, TP53, PIK3CA | APC, KRAS, TP53, PIK3CA | APC, KRAS, TP53, PIK3CA | |
TME | Decrease of CAFs | Decrease of CAFs | Decrease of CAFs | Increase of CAFs; Immunosuppressive signature | |
High immune and inflammatory signature | Low immune and inflammatory signature | Low immune and inflammatory signature |
Microorganism | Action | Ref. |
Bacterioides dorei, Bacterioides vulgatum, Parabacterioides distasonis, Lachnoclostridium sp., and Mordavella sp | Inhibit the action of factors related to CCSC phenotype. Inhibit CRC development and progression | [59,114] |
Bacterioides fragilis | Releases an enterotoxin that promotes immune TME cells activation with secretion of factors related to CCSC | [118] |
Citrobacter rodentium | Protects the inflammatory CCSC niche | [121] |
Clostridium septicum | Contributes to CRC development and to the activation of signaling pathways associated with CCSC | [59] |
Enterococcus faecalis | Induces the expression of TGF-β, thereby activating signaling pathways associated with CCSC. Activates Wnt/β-catenin signaling and pluripotent transcription factors associated with CCSC | [113,115] |
Escherichia coli | Upregulates the expression of CCSC-associated genes. Releases genotoxin colibactin which induces the production of growth factors related to CCSC | [112,117,79] |
Fusobacterium nucleatum | Stimulates the secretion of immune factors related to CCSC | [79] |
Helicobacter pylori | Promotes the expression of markers associated with stemness | [101,102] |
Lactobacillus acidophilus | Promotes proliferation or death in CCSC depending on dose | [104] |
Porphyromonas gingivalis | Promotes the expression of markers associated with stemness | [101,102] |
Shigella, and Citrobacter | Upregulate the expression of CCSC-associated genes | [112] |
- Citation: Novoa Díaz MB, Carriere P, Gentili C. How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells. World J Stem Cells 2023; 15(5): 281-301
- URL: https://www.wjgnet.com/1948-0210/full/v15/i5/281.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i5.281